We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Spire Healthcare sees FY in line with 2025 as interim profits fall

Wed 30 September 2026 07:09 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Private hospitals chain Spire Healthcare, about to be bought by a group of investment firms in a deal worth £1bn, posted lower first half operating profit of £38.4m down from £63m a year earlier.

Group revenue remained broadly flat at £792.7m, with accelerated growth in PMI, Self-Pay and Primary Care revenues, partially offsetting lower NHS activity following the previously announced funding-related slowdown in Q1, the company said on Wednesday.

Hospital revenue dipped 1.6% to £720.6m, with adjusted EBITDA down to £106.9m and margins easing to 14.8% on lower NHS activity. Private pay continued to grow, helped by investment in patient support centres, marketing and consultant recruitment.

SelfPay rose 4.5%, while PMI revenue increased 3.1% despite tighter claims authorisation. NHS revenue fell 14.3%, though the decline narrowed sharply in Q2 after commissioning plans were reset in April.

Primary Care delivered strong growth, with revenue up 8.1% to £72.1m and adjusted EBITDA rising 23.7% to £5.5m.

Adjusted loss before tax was £2.6m, compared with a £23.8m profit a year earlier, reflecting lower EBITDA and higher depreciation, amortisation and financing charges.

Tulip UK, comprised of funds managed or advised by Toscafund Asset Management, Spire's second largest shareholder, THCP Advisory and Ares Management offered 250p a share after months of talks.

The group said it continues to target annual adjusted EBITDA broadly in line with FY25, reiterating guidance despite lower NHS activity in the first half. Management highlighted strong visibility over NHS volumes, improving privatepay momentum and ongoing transformation savings as key supports for the second half.

Spire added that enhancements to patient access, clinical capacity and service development are expected to underpin marketshare gains, while disciplined capital allocation and robust cash generation provide further confidence in the fullyear outlook.

Reporting by Frank Prenesti for Sharecast.com

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More company news from ShareCast